PE0116 and PE0105 Injection in Treatment of Patients With Advanced Solid Tumor
Clinical trial NCT05801237 · RECRUITING
Trial details
- NCT number
- NCT05801237
- Sponsor
- Shanghai HyaMab Biotech Co.,Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-21
- Primary completion
- 2026-09-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.